[1]SanyalAJ, Campbell-SargentC , MirshahiF , etal.Non-alcoholicsteatohepatitis:associationofinsulinresistanceandmitochondrialabnor malities[J].Gastroenterology, 2001, 120∶1183-1192.
|
[2]YangSQ , ZhuH , LiY , etal.Mitochondrialadaptationstoobesity-re latedoxidantstress[J].ArchBiochemBiophys, 2000, 378∶259-268.
|
[3]LeclercqIA , FarrellGC , FieldJ, etal.CYP2E1andCYP4Aasmicro somalcatalystsoflipidperoxidesinmurinenon-alcoholicsteatohepatitis[J].JClinInvest, 2000, 05∶1067-1175.
|
[4]徐正婕, 范建高, 王国良, 等.高脂饮食致非酒精性脂肪性肝炎肝纤维化模型[J].世界华人消化杂志, 2002, 10 (4) ∶392-396.
|
[5]DayCP , JamesOFW .Steatohepatitis:ataleoftwo“hits”?[J].Gas troenterology, 1998, 114 (4) ∶842-845
|
[1] | Lingling ZHU, Yani ZHANG, Tingting SHI, Yang WU, Chun GAO, Xiaohui YU, Yujing HE, Jiucong ZHANG. The role of tumor necrosis factor-α in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(11): 2320-2325. doi: 10.12449/JCH241129 |
[2] | LI YongKang, YANG NenHong. Research advances in insulin resistance in chronic pancreatitis and pancreatic cancer[J]. Journal of Clinical Hepatology, 2020, 36(11): 2630-2632. doi: 10.3969/j.issn.1001-5256.2020.11.053 |
[3] | Chi ZhaoChun, Geng ZhangXin. Application of tumor necrosis factor antagonists in hepatic disease treatment[J]. Journal of Clinical Hepatology, 2015, 31(7): 1176-1179. doi: 10.3969/j.issn.1001-5256.2015.07.045 |
[4] | Zhang QiuNan, Xiao Ying, Miao RuiXin, Zhang YaQing, Zhu Ying. Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index,tumor necrosis factor- α,and interleukin- 6[J]. Journal of Clinical Hepatology, 2015, 31(7): 1078-1081. doi: 10.3969/j.issn.1001-5256.2015.07.019 |
[5] | Ma LiNa, Feng Ming, Zhou YingZhi, Ma Jia, Hao Peng. The relationship between nonalcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2010, 26(2): 173-174+177. |
[6] | Li Qiang, Chen Ming, Wang LiPing, Pan XiuCheng, Li ZhiYong. Relationship between serum Iron、Ferritin and lipid peroxidation injury in patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2008, 24(3): 183-185. |
[7] | Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279. |
[8] | Xu Hui, Wen QinSheng, Wang XuXia, Zhang YaFei, Li Jun, Gu BingQuan. The effect of cimetidine on the blood sugar, serum insulin and other indexes in NASH rats[J]. Journal of Clinical Hepatology, 2007, 23(2): 112-114. |
[9] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[10] | Yu XiaoHu, Zhu JinShui, Gu GuoMei, Shi JianPing. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(3): 195-196. |
[11] | Zhang Pin, Huang YanQing, Wang XueFen, Gong ZuoJiong. Effects of s-adenosylmethionine on methionine metabolism and lipid peroxidation of liver from rats with ethanol-induced liver injury[J]. Journal of Clinical Hepatology, 2007, 23(1): 31-33. |
[13] | Liang Bing, Chen Xi, Liu ShuangYan, Wang YiGe, An QiuHong. The relationship between non-alcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2006, 22(3): 213-214. |
[14] | Ma YingJie, Fang LiFeng, Feng SuPing, Jia KeLi, Fu ZhenLie. Obesity and insulin resistance in nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2002, 18(4): 241-242. |
[15] | Huang JiLiang, Wu Fang, Zhang XinRan, Wang DongHua, Zhao RuiZhi. Relationship between tumor necrosis factor-α and lnsulin resistance in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2002, 18(3): 166-167. |
[16] | Zhu YingHua, Song HongLi, Zhang Yi, Yu Guang, Han JiJin. The Clinieal study about interleukin-1 and tumor necrosis factor Alpha in hepatocirrhosis[J]. Journal of Clinical Hepatology, 2001, 17(4): 233-234. |